Drugs / Inavtivated Quadrivalent Influenza Virus Split Vaccine
Inavtivated Quadrivalent Influenza Virus Split Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05389137 | Mar → May 2022 | influenza | Wuhan Institute of Biological Products Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inavtivated Quadrivalent Influenza Virus Split Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05389137 ↗ |
| Modality | Vaccine | “quadrivalent split influenza virus vaccine” NCT05389137 ↗ |